Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years

Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years

There are limited data concerning the immunogenicity and reactogenicity of COVID-19 vaccines in children. A total of 110 children, 5–11 years old were vaccinated with two doses (with a 3-week interval between doses) of the Pfizer-BioNTech COVID-19 vaccine and were followed for 21, 90, and 180 days a...

Full description

Bibliographic Details
Main Authors: Gili Joseph, Elisheva Klein, Yaniv Lustig, Yael Weiss-Ottolenghi, Keren Asraf, Victoria Indenbaum, Sharon Amit, Or Kriger, Mayan Gilboa, Yuval Levy, Itai M. Pessach, Yitshak Kreiss, Gili Regev-Yochay, Michal Stein
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Vaccines
Subjects:
COVID-19
antibodies
children
vaccines
immunogenicity
reactogenicity
Online Access:https://www.mdpi.com/2076-393X/10/11/1954

Internet

https://www.mdpi.com/2076-393X/10/11/1954

Similar Items